U.S. STOCKS ON THE MOVE-Karyopharm, Oasmia, Sellas

Estre Ambiental

05/07/2019 12:42

* Eikon search string for individual stock moves:  STXBZ 
    * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
    * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh


    
U.S. stock futures edged lower, on Friday, as investors awaited the monthly jobs
data, which could offer clues on the Federal Reserve's move on interest
rates. N 
    At 6:58 a.m. ET, Dow e-minis  1YMc1  were down 0.12% at 26,937. S&P 500
e-minis  ESc1  were down 0.16% at 2,995.5, while Nasdaq 100 e-minis  NQc1  were
down 0.17% at 7,874.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Nio Inc  NIO.N , up 4.2%
 ** Alteryx Inc  AYX.N , up 4.1%
 ** Eros International Plc  EROS.N , up 3.7%
 
 The top NYSE percentage losers premarket  .PRPL.NQ :
 ** AllianceBernstein Holding LP  AB.N , down 4.9%
 ** Rio Tinto plc  RIO.N , down 4.2%
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Oasmia Pharmaceutical AB  OASM.O , up 41.5%
 ** DBV Technologies SA  DBVT.O , up 25.5%
 ** Sellas Life Sciences Group Inc  SLS.O , up 18.1%
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Melinta Therapeutics Inc  MLNT.O , down 12.8%
 ** Aethlon Medical Inc  AEMD.O , down 9.7%
 ** Estre Ambiental Inc  ESTR.O , down 9.5%
 
 
 ** Karyopharm Therapeutics Inc  KPTI.O : up 14.4% premarket
 BUZZ-FDA approval of Xpovio sets stage for label expansion  urn:newsml:reuters.com:*:nL4N2462ED
      

 (Compiled by Dominic Roshan K.L. in Bengaluru)
 ((Dominic.RoshanKL@thomsonreuters.com))